by TractManager | Jun 27, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Prolact+ H2MF (Prolacta Bioscience Inc.) human milk-derived human milk fortifier (HMF) for infants with very low...
by TractManager | Jun 27, 2024 | Emerging Technology Report
The pro2cool device is a portable head and neck cooling device under investigation for the treatment of adolescent mild traumatic brain injury (mTBI; concussion).
by TractManager | Jun 25, 2024 | Emerging Technology Report
Encoberminogene rezmadenovec (XyloCor Therapeutics Inc.) is an investigational gene therapy proposed for treatment of refractory angina pectoris. The therapy is administered directly to cardiac muscle via minithoracotomy.
by TractManager | Jun 25, 2024 | Emerging Technology Report
The Pulnovo Pulmonary Artery Denervation (PADN) catheter is an investigational pulmonary artery catheter intended for radiofrequency ablation of pulmonary nerves to treat pulmonary arterial hypertension (PAH) in adults.
by TractManager | Jun 24, 2024 | Emerging Technology Report
Bulevirtide (Gilead Sciences Inc.) is an investigational, first-in-class, subcutaneously injected virion entry inhibitor proposed for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease.
Recent Comments